Amlo Biosciences
Newcastle Upon Tyne · Founded 2017
About Amlo Biosciences
AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Last round: Series Unknown (Dec 2024)
- Website: http://www.amlo-biosciences.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/amlo-biosciences-55611 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.